144 related articles for article (PubMed ID: 22001741)
1. Primary immunodeficiency modeling with induced pluripotent stem cells.
Pessach IM; Notarangelo LD
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):505-11. PubMed ID: 22001741
[TBL] [Abstract][Full Text] [Related]
2. Primary immunodeficiencies.
Notarangelo LD
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S182-94. PubMed ID: 20042228
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
Mikkers H; Pike-Overzet K; Staal FJ
Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
[TBL] [Abstract][Full Text] [Related]
4. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs.
Quattrocelli M; Palazzolo G; Floris G; Schöffski P; Anastasia L; Orlacchio A; Vandendriessche T; Chuah MK; Cossu G; Verfaillie C; Sampaolesi M
J Pathol; 2011 Apr; 223(5):593-603. PubMed ID: 21341275
[TBL] [Abstract][Full Text] [Related]
6. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for primary immunodeficiencies.
Kildebeck E; Checketts J; Porteus M
Curr Opin Pediatr; 2012 Dec; 24(6):731-8. PubMed ID: 23073463
[TBL] [Abstract][Full Text] [Related]
9. Generation and genetic modification of induced pluripotent stem cells.
Schambach A; Cantz T; Baum C; Cathomen T
Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
[TBL] [Abstract][Full Text] [Related]
10. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
Liras A
Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
[TBL] [Abstract][Full Text] [Related]
11. The challenges and promises of blood engineered from human pluripotent stem cells.
Dravid GG; Crooks GM
Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells and primary immunodeficiencies: a new frontier reached, a new world beyond?
Gaspar HB
J Allergy Clin Immunol; 2011 Jun; 127(6):1408-9. PubMed ID: 21439622
[No Abstract] [Full Text] [Related]
13. Hematopoietic stem cell transplantation for primary immunodeficiency diseases.
Slatter MA; Cant AJ
Ann N Y Acad Sci; 2011 Nov; 1238():122-31. PubMed ID: 22129059
[TBL] [Abstract][Full Text] [Related]
14. Application of induced pluripotent stem cells to primary immunodeficiency diseases.
Karagiannis P; Yamanaka S; Saito MK
Exp Hematol; 2019 Mar; 71():43-50. PubMed ID: 30664903
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for primary immunodeficiencies.
Thrasher AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):457-71, xi. PubMed ID: 18424342
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cell transplantation for correction of primary immunodeficiencies.
Filipovich A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S49-S52. PubMed ID: 18724301
[TBL] [Abstract][Full Text] [Related]
18. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
19. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
20. Foreword: Hematopoietic stem cell transplantation for primary immunodeficiency disorders, part II.
Alam R
Immunol Allergy Clin North Am; 2010 May; 30(2):ix-x. PubMed ID: 20493391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
